Physician
Castelino, Ajith
Castelino, Ajith was paid $1.15M by Medicaid between Jan 2018 and Dec 2024, across 17 billing codes. Its largest line is J7320, Hyaluronan or derivitive, genvisc 850, for intra-articular injection, 1 mg — 36% of everything it billed.
33Billing provider infoCASTELINO, AJITH
CHICAGO, IL 60659
CHICAGO, IL 60659
33aNPI1760484042assigned 08/15/2005
33bProvider typePhysical Medicine & Rehabilitation Physician
28Total paid$1.15M
24GClaims40,513
24DCodes billed17
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers
Next to other Physical Medicine & Rehabilitation Physician providers in Illinois
Rank by total paid#2 of 229
Median peer was paid$16K
This provider vs. median73×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 5,567 | $62K | |
| 2019 | 5,510 | $88K | |
| 2020 | 5,096 | $140K | |
| 2021 | 6,024 | $249K | |
| 2022 | 6,658 | $263K | |
| 2023 | 6,741 | $188K | |
| 2024incomplete | 4,917 | $159K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| J7320 | Hyaluronan or derivitive, genvisc 850, for intra-articular injection, 1 mg | 36% | 4,191 | 1,878 | $416K |
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 19% | 7,353 | 5,594 | $221K |
| 99308 | Subsequent nursing facility care, per day, straightforward | 13% | 10,421 | 4,529 | $147K |
| 20611 | 9.4% | 8,899 | 3,976 | $108K | |
| 99309 | Subsequent nursing facility care, per day, low to moderate complexity | 4.6% | 2,369 | 1,829 | $52K |
| J7329 | Hyaluronan or derivative, trivisc, for intra-articular injection, 1 mg | 3.6% | 208 | 90 | $41K |
| 99306 | Prolong nursin fac eval 15m | 3.2% | 612 | 585 | $36K |
| J7324 | Hyaluronan or derivative, orthovisc, for intra-articular injection, per dose | 2.5% | 541 | 232 | $29K |
| 76881 | 2.4% | 915 | 758 | $28K | |
| 99204 | Doctor's office visit, new patient (more involved)Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity | 1.7% | 331 | 303 | $20K |
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 1.5% | 879 | 698 | $17K |
| J7321 | Hyaluronan or derivative, hyalgan, supartz or visco-3, for intra-articular injection, per dose | 1.3% | 312 | 124 | $14K |
5 more codes
| J1030 | Injection, methylprednisolone acetate, 40 mg | <1% | 2,868 | $9K |
| 97110 | Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion | <1% | 128 | $5K |
| 97140 | Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage) | <1% | 192 | $4K |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | <1% | 236 | $798.82 |
| J1010 | Injection, methylprednisolone acetate, 1 mg | <1% | 58 | $85.64 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.